Intellia Therapeutics, Inc. Quarterly Marketable Securities, Current in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Intellia Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2018 to Q2 2024.
  • Intellia Therapeutics, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $560M, a 23.9% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $560M -$176M -23.9% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $619M -$20.1M -3.14% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $685M +$16.4M +2.45% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $687M -$239K -0.04% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $736M +$9.77M +1.35% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $639M -$82.5M -11.4% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $669M +$43.8M +7.01% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $687M +$223M +48.2% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $726M +$327M +82% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $722M +$279M +63.1% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $625M +$188M +43% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $464M +$235M +103% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $399M +$324M +431% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $443M +$273M +161% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $437M +$215M +96.6% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $228M -$19.3M -7.79% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $75.1M -$147M -66.2% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $169M Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $223M -$32.7M -12.8% Dec 31, 2019 10-K 2021-02-26
Q3 2019 $247M Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $222M Jun 30, 2019 10-Q 2019-08-01
Q4 2018 $255M Dec 31, 2018 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.